Cambridge biotech firm Warp Drive Bio - which launched 18 months ago with $125 million in funding from Third Rock Ventures, Sanofi and Greylock Partners - said Tuesday that it has named company co-founder and longtime Harvard University professor Gregory Verdine as its new CEO.
http://www.bizjournals.com/boston/blog/startups/2013/07/warp-drive-bio-harvard-gregory-verdine.html?ana=RSS&s=article_search&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+vertical_32+%28Biotechnology+Industry+News%29
http://www.bizjournals.com/boston/blog/startups/2013/07/warp-drive-bio-harvard-gregory-verdine.html?ana=RSS&s=article_search&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+vertical_32+%28Biotechnology+Industry+News%29
No comments:
Post a Comment